Rezulin Liver Failure Causes FDA to Recall Drug

Home
>
Medicine
>
Rezulin Liver Failure Causes FDA to Recall Drug

Rezulin Liver Failure Causes FDA to Recall Drug

Rezulin, a prescription type 2 diabetes drug has been withdrawn from the market by the FDA. New drugs have come out which offer the benefits that Rezulin provides but without such damaging side effects. Rezulin caused extreme damage to the liver that often resulted in liver failure. Liver failure was so widespread amongst Rezulin users that there has been progressively increasing encouragement for these people to have frequent liver function tests to monitor liver damage. In fact, Rezulin users are 1200 times more likely to have liver failure than non-users of the drug.

Symptoms of liver damage that Rezulin users may experience are jaundice, fatigue, abdominal pain, weight loss, nausea and vomiting, loss of appetite, back pain and dark urine.

Prior to the development and release of less damaging diabetes 2 drugs, the FDA rushed to approve and lowered the safety standards for Rezulin. The FDA and Warner-Lambert, Rezulin's manufacturer, knew back in 1993 that Rezulin caused dangerous side effects including heart and liver damage or failure.

Due to the severe, damaging and sometimes lethal side effects of Rezulin, many have filed lawsuits against Pfizer, a drug manufacturing company, which just purchased Warner-Lambert, the drug manufacturing company responsible for the production of Rezulin. One woman was awarded $2 million in her Rezulin lawsuit. An Illinois class action suit won a $60 million settlement for compensation for medical treatment etc. that resulted from Rezulin side effects.

Contact an experienced Rezulin Lawyer today.

Find information about Rezulin Side Effects associated with a major Dangerous Drug Lawfirm today at hugesettlements.

In The News:

Mass High Tech
Blueprint Medicines Welcomes Fidelity Biosciences to Investor Syndicate
MarketWatch (press release)
CAMBRIDGE, Mass., May 24, 2012 (BUSINESS WIRE) -- Blueprint Medicines today announced that new investor Fidelity Biosciences joined existing founding investor Third Rock Ventures in its previously announced $40 million Series A financing.
Fidelity Biosciences invests in Blueprint MedicinesBoston.com

all 6 news articles »

Proactive Investors USA & Canada
Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor ...
MarketWatch (press release)
KALYDECO is the first medicine to treat the underlying cause of CF, a rare, genetic disease caused by defective or missing CFTR proteins resulting from mutations in the CFTR gene. In people with the G551D mutation, KALYDECO helps the defective CFTR ...
Vertex's cystic fibrosis treatment wins EU regulator's backingBoston.com
Vertex Pharma receives European recommendation for approval of cystic fibrosis ...Proactive Investors USA & Canada

all 20 news articles »

ASC settles with Medicine Hat man regarding allegations of illegal insider ...
Sacramento Bee
By Alberta Securities Commission CALGARY, May 24, 2012 -- /CNW/ - The Alberta Securities Commission (ASC) has concluded a settlement with Jeffrey Scott Bratvold of Medicine Hat, Alberta. Under the Settlement Agreement, Bratvold agreed to cease trading ...

and more »

Rewarding Excellence: Dental School Dean Receives Oral Medicine's Highest ...
UB News Center
BUFFALO, NY -- Michael Glick, DMD, professor of oral medicine and dean of the University at Buffalo School of Dental Medicine, has been presented with the highest academic award given by the American Academy of Oral Medicine (AAOM), conferred at their ...

and more »

EMA Recommends Patient, Prescriber Information For Pradaxa Be Updated
Wall Street Journal
LONDON (Dow Jones)--The European Medicines Agency, or EMA, Friday recommended updating the product information for the blood thinner Pradaxa, to give clearer guidance to doctors and patients on how to reduce and manage the risk of bleeding associated ...
European Medicines Agency Updates Patient and Prescriber Information for PradaxaPharmaLive.com (press release)

all 19 news articles »

EON: Enhanced Online News (press release)
The Center for Connected Medicine Welcomes GE Healthcare as Founding Partner
EON: Enhanced Online News (press release)
PITTSBURGH--(EON: Enhanced Online News)--The Center for Connected Medicine, a global thought leader defining the transformation of health care, today announced that GE Healthcare has joined the organization as a founding partner.
Health industry optimistic about curbing defensive medicineTire Business
GE becomes latest founding partner at Center for Connected MedicineCMIO
Medical association head talks presidential election, health-care reformIndUS Business Journal
Sioux City Journal
all 22 news articles »

Wilderness medicine courses offered in Eagle County
Vail Daily News
AVON, Colorado — Wilderness medicine classes are an essential tool for all that work, recreate and travel in the outdoors. Don't wait for something to go wrong on an expedition to learn about backcountry trauma and treatment.

There is Gluten in Medicine Too?
Patch.com (blog)
What if something in the medicine your doctor prescribes might make you sick, and neither your doctor nor pharmacist could tell what it is? This is a very real problem for the 3 million Americans with celiac disease and millions more with non-celiac ...

and more »

Homeopathy: It's Not Just Voodoo
Tucson Citizen
25, 2012, under Natural Medicine Tips I'ma skeptic (believe it or not). I've got a degree in biochemistry and molecular biophysics – that is to say, I'm not (as a general rule) satisfied to accept that something works if I can't explain why it works.

Best medicine: Yoga sessions let Amherst seniors laugh (with video)
The Morning Journal
By ASHLEY SZATALA AMHERST — At first glance, the Amherst Steele High School's gentle chair exercise laughter yoga session sounds like a group of Santa Clauses is in the room. It is the last session, and the senior citizen participants are bending, ...

Google News